Cover Image

Novel Action of the Chalcone Isoliquiritigenin as a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor: Potential Therapy for Cholera and Polycystic Kidney Disease

Overstimulation of cAMP-activated Cl− secretion can cause secretory diarrhea. Isoliquiritigenin (ISLQ) is a plant-derived chalcone that has a wide range of biological activities. The present study thus aimed to investigate the effect of ISLQ on cAMP-activated Cl− secretion in human intestinal epithe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chatchai Muanprasat (Author), Lalida Sirianant (Author), Sunhapas Soodvilai (Author), Ratchanaporn Chokchaisiri (Author), Apichart Suksamrarn (Author), Varanuj Chatsudthipong (Author)
Format:	Book
Published:	Elsevier, 2012-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inhibition of cAMP-activated intestinal chloride secretion by diclofenac: cellular mechanism and potential application in cholera.
by: Pawin Pongkorpsakol, et al.
Published: (2014)

An Adult Mouse Model of Vibrio cholerae-induced Diarrhea for Studying Pathogenesis and Potential Therapy of Cholera.
by: Sutthipong Sawasvirojwong, et al.
Published: (2013)

Discovery of a novel chalcone derivative inhibiting CFTR chloride channel via AMPK activation and its anti-diarrheal application
by: Chamnan Yibcharoenporn, et al.
Published: (2019)

Cellular mechanisms underlying the inhibitory effect of flufenamic acid on chloride secretion in human intestinal epithelial cells
by: Pawin Pongkorpsakol, et al.
Published: (2017)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
by: Ryosuke Fukuda, et al.
Published: (2020)

State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (<i>CFTR</i>) Modulators and Triple-Combination Therapy
by: Aniello Meoli, et al.
Published: (2021)

Pinostrobin inhibits renal CFTR-mediated Cl− secretion and retards cyst growth in cell-derived cyst and polycystic kidney disease rats
by: Kanlayanee Tonum, et al.
Published: (2022)

Double homozygous Cystic Fibrosis Transmembrane Regulator gene (CFTR) mutation: A case series and review of the literature
by: Hanaa Banjar, et al.
Published: (2020)

Fibrosis quística: patogenia bacteriana y moduladores del CFTR (regulador de conductancia transmembranal de la fibrosis quística)
by: Silvia Y. Vargas-Roldán, et al.
Published: (2022)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
by: Schmidt BZ, et al.
Published: (2016)

Natural statin derivatives as potential therapy to reduce intestinal fluid loss in cholera.
by: Rattikarn Noitem, et al.
Published: (2022)

Characterization of the Trafficking Pathway of Cystic Fibrosis Transmembrane Conductance Regulator in Baby Hamster Kidney Cells
by: Tsukasa Okiyoneda, et al.
Published: (2004)

A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe
by: Khadidja Abdallah, et al.
Published: (2021)

Paediatric Thoracic Imaging in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulation
by: Patrick W. O'Regan, et al.
Published: (2024)

Changes in cystic fibrosis transmembrane conductance regulator protein expression prior to and during elexacaftor-tezacaftor-ivacaftor therapy
by: Frauke Stanke, et al.
Published: (2023)

Effectiveness and Safety of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Children With Cystic Fibrosis: A Meta-Analysis
by: Qiyu Li, et al.
Published: (2022)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021)

CFTR Modulator Therapy for Rare CFTR Mutants
by: Marco Mergiotti, et al.
Published: (2022)

Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption
by: Nutthapoom Pathomthongtaweechai, et al.
Published: (2021)

Effect of particle size on the oral absorption of isoliquiritigenin nanocrystals
by: Yanni Ma, et al.
Published: (2023)

Isoliquiritigenin Inhibits Atherosclerosis by Blocking TRPC5 Channel Expression
by: Jie Qi, et al.
Published: (2020)

ANTIBACTERIAL AND IMMUNOTROPIC PROPERTIES OF ISOLIQUIRITIGENIN IN GENERALIZED STAPHYLOCOCCAL INFECTION IN MICE
by: E. A. Solyonova, et al.
Published: (2020)

Protective Effects of Isoliquiritigenin Against Methamphetamine-Induced Neurotoxicity in Mice
by: Min Jung Lee, et al.
Published: (2009)

The effects of trans-chalcone and chalcone 4 hydrate on the growth of Babesia and Theileria.
by: Gaber El-Saber Batiha, et al.
Published: (2019)

Aspirin and Some Other Nonsteroidal Anti-Inflammatory Drugs Inhibit Cystic Fibrosis Transmembrane Conductance Regulator Protein Gene Expression in T-84 Cells
by: Danielle Tondelier, et al.
Published: (1999)

Development of CFTR structure
by: Anna E Patrick, et al.
Published: (2012)

The inhibitory effect of Isoliquiritigenin on the proliferation of human arterial smooth muscle cell
by: Tianbao Chen, et al.
Published: (2017)

Prevalência da mutação ΔF508 no gene cystic fibrosis transmembrane conductance regulator em pacientes com fibrose cística em um centro de referência no Brasil Prevalence of ΔF508 mutation in the cystic fibrosis transmembrane conductance regulator gene among cystic fibrosis patients from a Brazilian referral center
by: Andréia Marisa Bieger, et al.
Published: (2012)

Efficacy and Safety of Triple Combination Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Patients With Cystic Fibrosis: A Meta-Analysis of Randomized Controlled Trials
by: Yizi Wang, et al.
Published: (2022)

Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications
by: Mangmang Qiu, et al.
Published: (2024)

Airway Epithelial Inflammation In Vitro Augments the Rescue of Mutant CFTR by Current CFTR Modulator Therapies
by: Martina Gentzsch, et al.
Published: (2021)

Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles
by: Soufyane Hba, et al.
Published: (2023)

Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years
by: Julian Berges, et al.
Published: (2023)

Investigating the Implications of CFTR Exon Skipping Using a Cftr Exon 9 Deleted Mouse Model
by: Kelly M. Martinovich, et al.
Published: (2022)

Isoliquiritigenin ameliorates abnormal oligodendrocyte development and behavior disorders induced by white matter injury
by: Dong Wu, et al.
Published: (2024)

Therapeutic Intervention in Cancer by Isoliquiritigenin from Licorice: A Natural Antioxidant and Redox Regulator
by: Zhu Zhang, et al.
Published: (2022)

Preparation and in vitro and in vivo evaluation of an isoliquiritigenin-loaded ophthalmic nanoemulsion for the treatment of corneal neovascularization
by: Rui Zhang, et al.
Published: (2022)

Isoliquiritigenin Alleviates Semen Strychni-Induced Neurotoxicity by Restoring the Metabolic Pathway of Neurotransmitters in Rats
by: Lu Wang, et al.
Published: (2021)

Long-Circulating and Brain-Targeted Liposomes Loaded with Isoliquiritigenin: Formation, Characterization, Pharmacokinetics, and Distribution
by: Weitong Song, et al.
Published: (2024)

Inhibitory effects of di-O-demethylcurcumin on interleukin-1β-induced interleukin-6 production from human gingival fibroblasts
by: Nuntana Aroonrerk, et al.
Published: (2012)